29
Views
99
CrossRef citations to date
0
Altmetric
Chromosome Structure and Dynamics

Mismatch Repair Proteins Are Activators of Toxic Responses to Chromium-DNA Damage

, , &
Pages 3596-3607 | Received 27 Oct 2004, Accepted 08 Feb 2005, Published online: 27 Mar 2023

REFERENCES

  • Acharya, S., T. Wilson, S. Gradia, M. F. Kane, S. Guerrette, G. T. Marsischky, R. Kolodner, and R. Fishel. 1996. hMSH2 forms specific mispair-binding complexes with hMSH3 and hMSH6. Proc. Natl. Acad. Sci. USA 93:13629–13634.
  • Aebi, S., B. Kurdi-Haidar, R. Gordon, B. Cenni, H. Zheng, D. Fink, R. D. Christen, C. R. Boland, M. Koi, R. Fishel, and S. B. Howell. 1996. Loss of DNA mismatch repair in acquired resistance to cisplatin. Cancer Res. 56:3087–3090.
  • Aquilina, G., M. Crescenzi, and M. Bignami. 1999. Mismatch repair, G2/M cell cycle arrest and lethality after DNA damage. Carcinogenesis 20:2317–2326.
  • Boyer, J. C., A. Umar, J. I. Risinger, J. R. Lipford, M. Kane, S. Yin, J. C. Barrett, R. D. Kolodner, and T. A. Kunkel. 1995. Microsatellite instability, mismatch repair deficiency, and genetic defects in human cancer cell lines. Cancer Res. 55:6063–6070.
  • Branch, P., G. Aquilina, M. Bignami, and P. Karran. 1993. Defective mismatch binding and a mutator phenotype in cells tolerant to DNA damage. Nature 362:652–654.
  • Brummelkamp, T. R., R. Bernards, and R. Agami. 2002. A system for stable expression of short interfering RNAs in mammalian cells. Science 296:550–553.
  • Canman, C. E., D. S. Lim, K. A. Cimprich, Y. Taya, K. Tamai, K. Sakaguchi, E. Appella, M. B. Kastan, and J. D. Siliciano. 1998. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281:1677–1679.
  • Carlisle, D. L., D. E. Pritchard, J. Singh, and S. R. Patierno. 2000. Chromium(VI) induces p53-dependent apoptosis in diploid human lung and mouse dermal fibroblasts. Mol. Carcinog. 28:111–118.
  • Cejka, P., L. Stojic, N. Mojas, A. M. Russell, K. Heinimann, E. Cannavo, M. di Pietro, G. Marra, and J. Jiricny. 2003. Methylation-induced G2/M arrest requires a full complement of the mismatch repair protein hMLH1. EMBO J. 22:2245–2254.
  • Clark, A. B., and T. A. Kunkel. 2004. Cadmium inhibits the functions of eukaryotic MutS complexes. J. Biol. Chem. 279:53903–53906.
  • Courcelle, J., J. R. Donaldson, K. H. Chow, and C. T. Courcelle. 2003. DNA damage-induced replication fork regression and processing in Escherichia coli. Science 299:1064–1067.
  • Drotschmann, K., R. P. Topping, J. E. Clodfelter, and F. R. Salsbury. 2004. Mutations in the nucleotide-binding domain of MutS homologs uncouple cell death from cell survival. DNA Repair (Amsterdam) 3:729–742.
  • Duckett, D. R., J. T. Drummond, A. I. Murchie, J. T. Reardon, A. Sancar, D. M. Lilley, and P. Modrich. 1996. Human MutSα recognizes damaged DNA base pairs containing O6-methylguanine, O4-methylthymine, or the cisplatin-d(GpG) adduct. Proc. Natl. Acad. Sci. USA 93:6443–6447.
  • Fishel, R. 1998. Mismatch repair, molecular switches, and signal transduction. Genes Dev. 12:2096–2101.
  • Genschel, J., S. J. Littman, J. T. Drummond, and P. Modrich. 1998. Isolation of MutSβ from human cells and comparison of the mismatch repair specificities of MutSβ and MutSα. J. Biol. Chem. 273:19895–19901.
  • Gong, J. G., A. Costanzo, H. Q. Yang, G. Melino, W. G. Kaelin, Jr., M. Levrero, and J. Y. Wang. 1999. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature 399:806–809.
  • Ha, L., S. Ceryak, and S. R. Patierno. 2003. Chromium (VI) activates ataxia telangiectasia mutated (ATM) protein. Requirement of ATM for both apoptosis and recovery from terminal growth arrest. J. Biol. Chem. 278:17885–17894.
  • Ha, L., S. Ceryak, and S. R. Patierno. 2004. Generation of S phase-dependent DNA double strand breaks by Cr(VI) exposure: involvement of ATM in Cr(VI) induction of γ-H2AX. Carcinogenesis 25:2265–2274.
  • Hickman, M. J., and L. D. Samson. 2004. Apoptotic signaling in response to a single type of DNA lesion, O(6)-methylguanine. Mol. Cell 14:105–116.
  • Hickman, M. J., and L. D. Samson. 1999. Role of DNA mismatch repair and p53 in signaling induction of apoptosis by alkylating agents. Proc. Natl. Acad. Sci. USA 96:10764–10769.
  • Hirose, T., K. Kondo, Y. Takahashi, H. Ishikura, H. Fujino, M. Tsuyuguchi, M. Hashimoto, T. Yokose, K. Mukai, T. Kodama, and Y. Monden. 2002. Frequent microsatellite instability in lung cancer from chromate-exposed workers. Mol. Carcinogenesis. 33:172–180.
  • Hoeijmakers, J. H. 2001. Genome maintenance mechanisms for preventing cancer. Nature 411:366–374.
  • Huang, X., M. Okafuji, F. Traganos, E. Luther, E. Holden, and Z. Darzynkiewicz. 2004. Assessment of histone H2AX phosphorylation induced by DNA topoisomerase I and II inhibitors topotecan and mitoxantrone and by the DNA cross-linking agent cisplatin. Cytometry A 58A:99–110.
  • Hwang, A., A. Maity, W. G. McKenna, and R. J. Muschel. 1995. Cell cycle-dependent regulation of the cyclin B1 promoter. J. Biol. Chem. 270:28419–28424.
  • Jin, Y. H., A. B. Clark, R. J. Slebos, H. Al-Refai, J. A. Taylor, T. A. Kunkel, M. A. Resnick, and D. A. Gordenin. 2003. Cadmium is a mutagen that acts by inhibiting mismatch repair. Nat. Genet. 34:326–329.
  • Jiricny, J., and M. Nystrom-Lahti. 2000. Mismatch repair defects in cancer. Curr. Opin. Genet. Dev. 10:157–161.
  • Karran, P. 2001. Mechanisms of tolerance to DNA damaging therapeutic drugs. Carcinogenesis 22:1931–1937.
  • Kolodner, R. D. 1996. Mismatch repair in replication fidelity, genetic recombination, and cancer biology. Annu. Rev. Biochem. 65:101–133.
  • Kolodner, R. D., and G. T. Marsischky. 1999. Eukaryotic DNA mismatch repair. Curr. Opin. Genet. Dev. 9:89–96.
  • Kondo, K., N. Hino, M. Sasa, Y. Kamamura, S. Sakiyama, M. Tsuyuguchi, M. Hashimoto, T. Uyama, and Y. Monden. 1997. Mutations of the p53 gene in human lung cancer from chromate-exposed workers. Biochem. Biophys. Res. Commun. 239:95–100.
  • Kortenkamp, A., M. Casadevall, and P. Da Cruz Fresco. 1996. The reductive conversion of the carcinogen chromium (VI) and its role in the formation of DNA lesions. Ann. Clin. Lab. Sci. 26:160–175.
  • Langard, S. 1990. One hundred years of chromium and cancer: a review of epidemiological evidence and selected case reports. Am. J. Ind. Med. 17:189–215.
  • Lin, D. P., Y. Wang, S. J. Scherer, A. B. Clark, K. Yang, E. Avdievich, B. Jin, U. Werling, T. Parris, N. Kurihara, A. Umar, R. Kucherlapati, M. Lipkin, T. A. Kunkel, and W. Edelmann. 2004. An Msh2 point mutation uncouples DNA mismatch repair and apoptosis. Cancer Res. 64:517–522.
  • Mattagajasingh, S. N., and H. P. Misra. 1999. Analysis of EDTA-chelatable proteins from DNA-protein crosslinks induced by a carcinogenic chromium(VI) in cultured intact human cells. Mol. Cell. Biochem. 199:149–162.
  • Mellon, I., D. K. Rajpal, M. Koi, C. R. Boland, and G. N. Champe. 1996. Transcription-coupled repair deficiency and mutations in human mismatch repair genes. Science 272:557–560.
  • O'Brien, T., H. G. Mandel, D. E. Pritchard, and S. R. Patierno. 2002. Critical role of chromium (Cr)-DNA interactions in the formation of Cr-induced polymerase arresting lesions. Biochemistry 41:12529–12537.
  • O'Brien, T., J. Xu, and S. R. Patierno. 2001. Effects of glutathione on chromium-induced DNA crosslinking and DNA polymerase arrest. Mol. Cell. Biochem. 222:173–182.
  • Ochs, K., and B. Kaina. 2000. Apoptosis induced by DNA damage O6-methylguanine is Bcl-2 and caspase-9/3 regulated and Fas/caspase-8 independent. Cancer Res. 60:5815–5824.
  • Papouli, E., P. Cejka, and J. Jiricny. 2004. Dependence of the cytotoxicity of DNA-damaging agents on the mismatch repair status of human cells. Cancer Res. 64:3391–3394.
  • Park, J. S., E. J. Kim, J. Y. Lee, H. S. Sin, S. E. Namkoong, and S. J. Um. 2001. Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins. Int. J. Cancer 91:822–827.
  • Prolla, T. A., S. M. Baker, A. C. Harris, J. L. Tsao, X. Yao, C. E. Bronner, B. Zheng, M. Gordon, J. Reneker, N. Arnheim, D. Shibata, A. Bradley, and R. M. Liskay. 1998. Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms1 and Pms2 DNA mismatch repair. Nat. Genet. 18:276–279.
  • Quievryn, G., J. Messer, and A. Zhitkovich. 2002. Carcinogenic chromium(VI) induces cross-linking of vitamin C to DNA in vitro and in human lung A549 cells. Biochemistry 41:3156–3167.
  • Quievryn, G., E. Peterson, J. Messer, and A. Zhitkovich. 2003. Genotoxicity and mutagenicity of chromium(VI)/ascorbate-generated DNA adducts in human and bacterial cells. Biochemistry 42:1062–1070.
  • Reynolds, M., E. Peterson, G. Quievryn, and A. Zhitkovich. 2004. Human nucleotide excision repair efficiently removes chromium-DNA phosphate adducts and protects cells against chromate toxicity. J. Biol. Chem. 279:30419–30424.
  • Rogakou, E. P., C. Boon, C. Redon, and W. M. Bonner. 1999. Megabase chromatin domains involved in DNA double-strand breaks in vivo. J. Cell Biol. 146:905–916.
  • Sherwood, S. W., D. F. Rush, A. L. Kung, and R. T. Schimke. 1994. Cyclin B1 expression in HeLa S3 cells studied by flow cytometry. Exp. Cell Res. 211:275–281.
  • Shimodaira, H., A. Yoshioka-Yamashita, R. D. Kolodner, and J. Y. Wang. 2003. Interaction of mismatch repair protein PMS2 and the p53-related transcription factor p73 in apoptosis response to cisplatin. Proc. Natl. Acad. Sci. USA 100:2420–2425.
  • Sogo, J. M., M. Lopes, and M. Foiani. 2002. Fork reversal and ssDNA accumulation at stalled replication forks owing to checkpoint defects. Science 297:599–602.
  • Stojic, L., N. Mojas, P. Cejka, M. Di Pietro, S. Ferrari, G. Marra, and J. Jiricny. 2004. Mismatch repair-dependent G2 checkpoint induced by low doses of SN1 type methylating agents requires the ATR kinase. Genes Dev. 18:1331–1344.
  • Strauss-Soukup, J. K., M. M. Vaghefi, R. I. Hogrefe, and L. J. Maher, 3rd. 1997. Effects of neutralization pattern and stereochemistry on DNA bending by methylphosphonate substitutions. Biochemistry 36:8692–8698.
  • Suzuki, Y., and K. Fukuda. 1990. Reduction of hexavalent chromium by ascorbic acid and glutathione with special reference to the rat lung. Arch. Toxicol. 64:169–176.
  • Taioli, E., A. Zhitkovich, P. Kinney, I. Udasin, P. Toniolo, and M. Costa. 1995. Increased DNA-protein crosslinks in lymphocytes of residents living in chromium-contaminated areas. Biol. Trace Elem. Res. 50:175–180.
  • Tsao, J. L., Y. Yatabe, R. Salovaara, H. J. Jarvinen, J. P. Mecklin, L. A. Aaltonen, S. Tavare, and D. Shibata. 2000. Genetic reconstruction of individual colorectal tumor histories. Proc. Natl. Acad. Sci. USA 97:1236–1241.
  • Tsou, T. C., H. J. Lai, and J. L. Yang. 1999. Effects of mannitol or catalase on the generation of reactive oxygen species leading to DNA damage by chromium(VI) reduction with ascorbate. Chem. Res. Toxicol. 12:1002–1009.
  • Voitkun, V., A. Zhitkovich, and M. Costa. 1998. Cr(III)-mediated crosslinks of glutathione or amino acids to the DNA phosphate backbone are mutagenic in human cells. Nucleic Acids Res. 26:2024–2030.
  • Wang, S., and X. Shi. 2001. Mechanisms of Cr(VI)-induced p53 activation: the role of phosphorylation, mdm2 and ERK. Carcinogenesis 22:757–762.
  • Wang, Y., D. Cortez, P. Yazdi, N. Neff, S. J. Elledge, and J. Qin. 2000. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev. 14:927–939.
  • Wang, Y., and J. Qin. 2003. MSH2 and ATR form a signaling module and regulate two branches of the damage response to DNA methylation. Proc. Natl. Acad. Sci. USA 100:15387–15392.
  • Watanabe, Y., A. Haugen-Strano, A. Umar, K. Yamada, H. Hemmi, Y. Kikuchi, S. Takano, Y. Shibata, J. C. Barrett, T. A. Kunkel, and M. Koi. 2000. Complementation of an hMSH2 defect in human colorectal carcinoma cells by human chromosome 2 transfer. Mol. Carcinog. 29:37–49.
  • Wheeler, J. M., W. F. Bodmer, and N. J. Mortensen. 2000. DNA mismatch repair genes and colorectal cancer. Gut 47:148–153.
  • Yang, G., S. J. Scherer, S. S. Shell, K. Yang, M. Kim, M. Lipkin, R. Kucherlapati, R. D. Kolodner, and W. Edelmann. 2004. Dominant effects of an Msh6 missense mutation on DNA repair and cancer susceptibility. Cancer Cell 6:139–150.
  • Ye, J., S. Wang, S. S. Leonard, Y. Sun, L. Butterworth, J. Antonini, M. Ding, Y. Rojanasakul, V. Vallyathan, V. Castranova, and X. Shi. 1999. Role of reactive oxygen species and p53 in chromium(VI)-induced apoptosis. J. Biol. Chem. 274:34974–34980.
  • Zhitkovich, A., Y. Song, G. Quievryn, and V. Voitkun. 2001. Non-oxidative mechanisms are responsible for the induction of mutagenesis by reduction of Cr(VI) with cysteine: role of ternary DNA adducts in Cr(III)-dependent mutagenesis. Biochemistry 40:549–560.
  • Zhitkovich, A., V. Voitkun, and M. Costa. 1996. Formation of the amino acid-DNA complexes by hexavalent and trivalent chromium in vitro: importance of trivalent chromium and the phosphate group. Biochemistry 35:7275–7282.
  • Zhitkovich, A., V. Voitkun, and M. Costa. 1995. Glutathione and free amino acids form stable complexes with DNA following exposure of intact mammalian cells to chromate. Carcinogenesis 16:907–913.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.